Patents by Inventor Roberto Takashi Sudo

Roberto Takashi Sudo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8217068
    Abstract: The present invention is related to a new series of chemical compounds, namely 3-benzyl-imidazolidine-2,4-dione substituted in the position 2 and/or 6 of benzyl ring by halogens as presented to the molecule named LPSF-PT-31, GIRSUPAN and its therapeutic use as drug with analgesic, sedative and adjuvant of anesthetics activities. The invention is also related to a process for production of said compounds as well as pharmaceutical compositions comprising them.
    Type: Grant
    Filed: May 5, 2008
    Date of Patent: July 10, 2012
    Assignees: Universidade Federal de Pernambuco—UFPE, Universidade Federal do Rio de Janeiro—UFRJ
    Inventors: Ivan Da Rocha Pitta, Maria Do Carmo Alves De Lima, Teresinha Gonçalves da Silva, Gisele Zapata Sudo, Suely Lins Galdino, Roberto Takashi Sudo
  • Publication number: 20100130575
    Abstract: The present invention is related to a new series of chemical compounds, namely 3-benzyl-imidazolidine-2,4-dione substituted in the position 2 and/or 6 of benzyl ring by halogens as presented to the molecule named LPSF-PT-31, GIRSUPAN and its therapeutic use as drug with analgesic, sedative and adjuvant of anesthetics activities. The invention is also related to a process for production of said compounds as well as pharmaceutical compositions comprising them.
    Type: Application
    Filed: May 5, 2008
    Publication date: May 27, 2010
    Inventors: Ivan Da Rocha Pitta, Maria Do Carmo Alves De Lima, Teresinha Goncalves Da Silva, Gisele Zapata Sudo, Suely Lins Galdino, Roberto Takashi Sudo
  • Publication number: 20080275105
    Abstract: This invention refers to substances able to cause selective muscle relaxation, pharmaceutical compositions containing such compounds and their use in the treatment of muscle tissue diseases, with such compounds complying with the general formula (I).
    Type: Application
    Filed: August 19, 2005
    Publication date: November 6, 2008
    Applicant: UNIVERSIDADE FEDERAL DO RIO DE JANEIROUFRJ
    Inventors: Carlos Alberto Manssour Fraga, Eliezer de Jesus de Lacerda Barreiro, Arthur Eugen Kummerle, Alexandre Godinho Silva, Roberto Takashi Sudo, Gisele Zapata-Sudo
  • Patent number: 7091238
    Abstract: The invention discloses a compound having the formula (I) wherein R1 is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms, unsubstituted phenyl, and substituted phenyl; R2 is selected from the group consisting of H, alkene, un-substituted phenol, and substituted phenyl; and pharmaceutically acceptable salts thereof, having digitalis-like properties. The invention further discloses a novel method to synthesize 3,4-methylenedioxybenzoyl-2-thienylhydrazone (LASSBio-294). LASSBio-294 produces positive inotropic effect on cardiac and skeletal muscle. The invention is useful for the treatment of congestive heart failure and muscle fatigue. It lacks toxic effects seen in digitalis glycosides.
    Type: Grant
    Filed: June 21, 2000
    Date of Patent: August 15, 2006
    Assignee: University of Maryland
    Inventors: Roberto Takashi Sudo, Edson X. Albuquerque, Eliezer J. De Barreiro, Yasco Aracava, Wagner Monteiro Cintra, Paulo De Assis Melo, Francois Germain Noel, Gisele Zapata Sudo, Claudia Lucia Martins Da Silva, Newton Goncalves de Castro, Patricia Dias Fernandes, Carlos Alberto Manssour Fraga, Ana Luisa Palhares De Miranda